Quantitative impact of using different criteria for the laboratory diagnosis of type 1 von Willebrand disease

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 8, 2014, Pages 1238-1243

  Quiroga, T ^a   Goycoolea, M ^a   Belmont, S ^a   Panes, O ^a   Aranda, E ^a   Zuniga P ^a   Pereira, J ^a   Mezzano, D ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Blood coagulation disorders, inherited; Diagnosis; Hematologic tests; Von Willebrand disease, type 1; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR; RISTOCETIN COFACTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; AUTOANTIGEN;

ARTICLE; BINDING ASSAY; CHILD; COLLAGEN BINDING ASSAY; CONTROLLED STUDY; DISEASE CLASSIFICATION; EUROPEAN GROUP ON VON WILLEBRAND DISEASE CRITERIA; FEMALE; HUMAN; INFANT; INSTITUTIONAL REVIEW; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; NATIONAL HEART LUNG AND BLOOD INSTITUTE RECOMMENDATION CRITERIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VON WILLEBRAND DISEASE; ZIMMERMAN PROGRAM FOR MOLECULAR AND CLINICAL BIOLOGY OF VWD CRITERIA; BLOOD; DIAGNOSTIC PROCEDURE; RETROSPECTIVE STUDY; VON WILLEBRAND DISEASE, TYPE 1;

AUTOANTIGENS; CLINICAL LABORATORY TECHNIQUES; HUMANS; RETROSPECTIVE STUDIES; VON WILLEBRAND DISEASE, TYPE 1;

EID: 84905675810     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12594     Document Type: Article

References (19)

1. Favaloro EJ. von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder. Semin Thromb Hemost 2011; 37: 440-55.
2. Lillicrap D. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Blood 2013; 122: 3735-40.
3. Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS. Serial studies in von Willebrand's disease: variability versus "variants". Blood 1980; 56: 712-6.
4. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
5. Sadler JE. Slippery criteria for von Willebrand disease type 1. J Thromb Haemost 2004; 2: 1720-3.
6. Sadler JE, Rodeghiero F. Factor ISSovW. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3: 775-7.
7. Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, Rick ME, Sadler JE, Weinstein M, Yawn BP. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14: 171-232.
8. Quiroga T, Mezzano D. Is my patient a bleeder? A diagnostic framework for mild bleeding disorders. Hematology Am Soc Hematol Educ Program 2012; 2012: 466-74.
9. Castaman G, Goodeve A, Eikenboom J. Principles of care for the diagnosis and treatment of von Willebrand disease. Haematologica 2013; 98: 667-74.
10. Lillicrap D. Translational medicine advances in von Willebrand disease. J Thromb Haemost 2013; 11 (Suppl. 1): 75-83.
11. Bellissimo DB, Christopherson PA, Flood VH, Gill JC, Friedman KD, Haberichter SL, Shapiro AD, Abshire TC, Leissinger C, Hoots WK, Lusher JM, Ragni MV, Montgomery RR. VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population. Blood 2012; 119: 2135-40.
12. James PD, Lillicrap D. The molecular characterization of von Willebrand disease: good in parts. Br J Haematol 2013; 161: 166-76.
13. Sadler JE. von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-93.
14. Branchford BR, Di Paola J. Making a diagnosis of VWD. Hematology Am Soc Hematol Educ Program 2012; 2012: 161-7.
15. Montgomery RR, Christopherson P, Bellissimo DB, Gill JC, Haberichter SL, Flood VH, Lillicrap D, Goodeve AC, Friedman KD, Abshire TC, Shapiro AD, Ragni MV, Lentz SR, Leissinger CA, Dunn AL, Lusher J, Brown D. The complete type I VWD cohort of the Zimmerman Program for the Molecular and Clinical Biology of VWD - Phenotypic assignment, mutation frequency, and bleeding assessment. Blood 2013; 122: 332 (Abstract).
16. Quiroga T, Goycoolea M, Panes O, Aranda E, Martinez C, Belmont S, Munoz B, Zuniga P, Pereira J, Mezzano D. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 2007; 92: 357-65.
17. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-60.
18. Flood VH, Gill JC, Friedman KD, Bellissimo DB, Haberichter SL, Montgomery RR. von Willebrand disease in the United States: a perspective from Wisconsin. Semin Thromb Hemost 2011; 37: 528-34.
19. Favaloro EJ, Bonar R, Favaloro J, Koutts J. Diagnosis and management of von Willebrand disease in Australia. Semin Thromb Hemost 2011; 37: 542-54.